Andere Sprachen iCAD, Inc.

Aktien

A1J20J

US44934S2068

ICAD

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:14:03 29.04.2024			% 5 Tage	% 1. Jan.
1,47 ^USD	0,00 %		-0,09 %	-14,20 %

11.04.	ICAD, Inc. stellt auf dem SBI-Jahressymposium die neue Profound Cloud und die erweiterten Funktionen der Profound Detection Workstation vor	CI
09.04.	ICAD, Inc. und Densitas, Inc. Partnerschaft zur Verbesserung der präzisen Brustgesundheit mit führenden KI-Lösungen für Mammographiequalität, Krebserkennung und Risikobewertung	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ICAD Showcases New ProFound Cloud, Enhanced ProFound Detection Workstation Features and New Strategic Partnerships at SBI Annual Symposium	11.04.
ICAD, Inc. Showcases New Profound Cloud, Enhanced Profound Detection Workstation Features at SBI Annual Symposium	11.04.
ICAD and Densitas Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	09.04.
ICAD, Inc. and Densitas, Inc. Partner to Enhance Precision Breast Health with Leading AI Solutions for Mammography Quality, Cancer Detection, and Risk Evaluation	09.04.
ICAD’s ProFound AI Suite Uncovers Hidden Heart Disease Risk According to New Data Presented at American College of Cardiology Meeting	08.04.
ICAD Partners with RAD-AID to Advance Breast Cancer Detection Using AI in Underserved Regions and Low- and Middle-Income Countries (LMICs)	03.04.
ICAD Unveils ProFound Cloud, Enabling Interoperability and Access to Breast AI Solutions at Enterprise Scale	02.04.
ICAD, Inc. Announces Commercial Availability of ProFound Cloud	02.04.
ICAD Releases Enhanced ProFound Detection Workstation Features to Streamline Mammogram Interpretation for Radiologists	19.03.
Earnings Flash (ICAD) ICAD Posts Q4 Revenue $4.7M, vs. Street Est of $4.3M	12.03.
ICAD, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	12.03.
ICAD Announces Fiscal Fourth Quarter and Full-Year 2023 Financial Results	12.03.
ICad to Present Three Mammography Studies at Radiology Conference; Shares Rise	28.02.
ICAD Highlights Promising Clinical Data Demonstrating Ability to Reduce Breast Interval Cancer Rates and Decrease Recall Rates at ECR 2024; Showcases Additional Platform Offerings	28.02.
ICAD expands Board of Directors with the appointment of Dr. Hedvig Hricak, MD, PhD, (Dr.h.cᵐ)	27.02.
ICAD to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024	27.02.
ICAD, Inc. Appoints Hedvig Hricak to the Board of Directors	26.02.
ICAD to Participate in the BTIG at Snowbird: 11th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference	06.02.
ICAD Expands Board of Directors with Appointment of Michael J. Doyle, FACHE as New Board Member	30.01.
ICAD, Inc. Appoints Michael John Doyle to its Board of Directors	25.01.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen iCAD, Inc.

Aktien

A1J20J

US44934S2068

ICAD

Andere Sprachen

Filter